These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28736929)

  • 21. The use of disease-modifying agents among multiple sclerosis patients enrolled in medicare from 1995 to 2002 and the impact of medicare part D: analysis of claims data from the medicare current beneficiary survey.
    Lundy J; Craig BM
    Clin Ther; 2006 Jan; 28(1):140-5. PubMed ID: 16490588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.
    Sacks NC; Burgess JF; Cabral HJ; Pizer SD; McDonnell ME
    J Gen Intern Med; 2013 Jul; 28(7):876-85. PubMed ID: 23404199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction.
    Stuart B; Davidoff A; Erten M; Gottlieb SS; Dai M; Shaffer T; Zuckerman IH; Simoni-Wastila L; Bryant-Comstock L; Shenolikar R
    Health Serv Res; 2013 Dec; 48(6 Pt 1):1960-77. PubMed ID: 23742013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11.
    Trish E; Joyce G; Goldman DP
    Health Aff (Millwood); 2014 Nov; 33(11):2018-24. PubMed ID: 25367998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myopic and Forward Looking Behavior in Branded Oral Anti-Diabetic Medication Consumption: An Example from Medicare Part D.
    Sacks NC; Burgess JF; Cabral HJ; Pizer SD
    Health Econ; 2017 Jun; 26(6):753-764. PubMed ID: 27150938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs.
    Fung V; Price M; Busch AB; Landrum MB; Fireman B; Nierenberg A; Dow WH; Hui R; Frank R; Newhouse JP; Hsu J
    Med Care; 2013 Jul; 51(7):614-21. PubMed ID: 23752219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes.
    Stuart B; Yin X; Davidoff A; Simoni-Wastila L; Zuckerman I; Shoemaker JS; Doshi J
    Med Care; 2012 Nov; 50(11):913-9. PubMed ID: 23047779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.
    Kuye IO; Frank RG; McWilliams JM
    JAMA Intern Med; 2013 Jun; 173(12):1100-7. PubMed ID: 23649604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.
    Depue R; Stubbings J
    J Manag Care Pharm; 2008; 14(1):50-60. PubMed ID: 18240882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicare Part D low-income subsidies expanded in January 2024, but more needs to be done to ensure that eligible beneficiaries enroll.
    Loh FE; Stuart BC; Hunt RJ; Negari M
    J Manag Care Spec Pharm; 2024 Mar; 30(3):279-289. PubMed ID: 38324387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL; Cox ER
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D.
    Riley GF; Warren JL; Harlan LC; Blackwell SA
    Medicare Medicaid Res Rev; 2011 Dec; 1(4):. PubMed ID: 22340780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.
    Wei II; Lloyd JT; Shrank WH
    J Am Geriatr Soc; 2013 Aug; 61(8):1315-23. PubMed ID: 23889465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-gap discounts in Medicare Part D and specialty drug use.
    Jung J; Xu WY; Cheong C
    Am J Manag Care; 2017 Sep; 23(9):553-559. PubMed ID: 29087157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis.
    Desai RJ; Rao JK; Hansen RA; Fang G; Maciejewski ML; Farley JF
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1110-20. PubMed ID: 25351972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing patient OOP spending for specialty drugs in Medicare Part D and employer-sponsored insurance.
    Parasrampuria S; Sen AP; Anderson GF
    Am J Manag Care; 2020 Sep; 26(9):388-394. PubMed ID: 32930551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.